Table of contents
January 2008 Volume 4 No 1
Free Sample Issue
Full text content of the January 2008 issue is freely available in both HTML and PDF formats.
Editorial
The third World Kidney Day: looking back and thinking forward
1doi:10.1038/ncpneph0702 | Full Text | PDF (141K)
Viewpoint
Screening for chronic kidney disease in patients with diabetes: are we missing the point?
2Screening for chronic kidney disease in patients with diabetes should encompass not only testing for albuminuria, but also the subsequent diagnostic procedures and interventions. Otherwise, what is the purpose of testing? The authors of this Viewpoint highlight the inadequacies of current screening practices, and argue that detection of increased urinary albumin excretion in a patient with diabetes should be a call to action.
doi:10.1038/ncpneph0679 | Full Text | PDF (166K)
Research Highlights
Coenzyme Q10 deficiency with renal involvement: a newly characterized disorder
4doi:10.1038/ncpneph0648 | Full Text | PDF (101K)
A low-cost salt substitute reduces blood pressure in high-risk individuals
4Restoring nightly blood pressure dip by altering timing of antihypertensive therapy in CKD
4New treatment algorithms for idiopathic glomerular disease
5Tacrolimus effective in steroid-dependent minimal change nephrotic syndrome
5doi:10.1038/ncpneph0666 | Full Text | PDF (101K)
Bioplorer® enables rapid quantification of microbial contamination of dialysate
6Biocompatible peritoneal dialysis solutions are not superior to conventional solutions
6Why do dialysis patients with AMI have such poor outcomes?
7Aspirin prescription does not reduce the risk of cardiac events in patients on hemodialysis
7Hemodialysis patients with low vitamin D levels are at increased risk of early mortality
7Higher serum creatinine paradoxically associated with better survival in AKI
8Pre-emptive management of polyomavirus BK in pediatric kidney transplant recipients
8Systematic review of ARB and ACE inhibitor use in kidney transplant recipients
9Practice Points
Are oral antibiotics alone efficacious for the treatment of a first episode of acute pyelonephritis in children?
10doi:10.1038/ncpneph0662 | Full Text | PDF (176K)
Comparing the cerebroprotective properties of antihypertensive drugs in terms of their effects on angiotensin
12doi:10.1038/ncpneph0672 | Full Text | PDF (175K)
Intravenous methylprednisolone or plasma exchange for adjunctive therapy of severe renal vasculitis?
14doi:10.1038/ncpneph0650 | Full Text | PDF (175K)
Previous abdominal surgery is not necessarily a contraindication for peritoneal dialysis
16doi:10.1038/ncpneph0669 | Full Text | PDF (173K)
Utility of oral valganciclovir for the treatment of cytomegalovirus disease after renal transplantation
18doi:10.1038/ncpneph0642 | Full Text | PDF (175K)
New-onset diabetes after renal transplantation: comparing ciclosporin and tacrolimus
20doi:10.1038/ncpneph0640 | Full Text | PDF (177K)
ACE inhibition after renal transplantation: the effect on persistent left ventricular hypertrophy
22doi:10.1038/ncpneph0663 | Full Text | PDF (176K)
Reviews

Inherited diseases of the glomerular basement membrane
24Here, Dr Gubler describes the pathogenesis of disorders that affect components of the glomerular basement membrane, including type III and type IV collagen, laminin and fibronectin. Dr Gubler harnesses her considerable clinical experience to recommend diagnostic and management strategies for Alport syndrome, Pierson syndrome, nail–patella syndrome, benign familial hematuria/thin basement membrane nephropathy, and glomerulopathies caused by errant deposition of fibronectin and type III collagen.
doi:10.1038/ncpneph0671 | Full Text | PDF (1,386K)

Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance
38Knowledge regarding this important system of renal chloride transporters has rapidly accumulated. A severe salt-losing tubulopathy—Bartter syndrome type III—develops when ClCKB is non-functional, whereas a common genetic variant of the CLCNKB gene results in salt-dependent hypertension. Disruption of the Barttin gene manifests as Bartter syndrome type IV with sensorineural deafness and an especially severe salt-losing phenotype. It is timely, therefore, to review the properties of these transporters.
doi:10.1038/ncpneph0689 | Full Text | PDF (423K)
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
47Anemia is associated with exacerbation of both renal and cardiac disease. A considerable proportion of patients whose anemia is treated with erythropoietin do not respond, and the safety and efficacy of this therapy in people that have both chronic heart and kidney disease has not been proven. Overcoming erythropoietin resistance in this population must be predicated on understanding the processes that contribute to this state. These are reviewed here.
doi:10.1038/ncpneph0655 | Full Text | PDF (458K)


